Robert L Nussbaum Invitae Corp (NVTA) insider trading activity

NVTA Quotes by TradingView

Robert L Nussbaum is Chief Medical Officer of Invitae Corp. Currently has a direct ownership of 551,941 shares of NVTA, which is worth approximately $0. The most recent transaction as insider was on Dec 20, 2023, when has been sold 17,404 shares (Common Stock) at a price of $0.65 per share, resulting in proceeds of $11,312. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 552K
0% 3M change
3.06% 12M change
Total Value Held $0

Robert L Nussbaum Transaction History

Date Transaction Value Shares Traded Shares Held Form
Dec 20 2023
SELL
Payment of exercise price or tax liability
$11,312 $0.65 p/Share
17,404 Reduced 3.06%
551,941 Common Stock
Jun 13 2023
SELL
Open market or private sale
$9,778 $1.38 p/Share
7,086 Reduced 1.23%
569,345 Common Stock
May 16 2023
SELL
Open market or private sale
$31,771 $1.2 p/Share
26,476 Reduced 4.39%
576,431 Common Stock
Apr 03 2023
BUY
Grant, award, or other acquisition
-
155,000 Added 20.45%
602,907 Common Stock
Mar 13 2023
SELL
Open market or private sale
$3,701 $1.41 p/Share
2,625 Reduced 0.58%
447,907 Common Stock
Aug 22 2022
BUY
Grant, award, or other acquisition
-
54,000 Added 10.7%
450,532 Common Stock
Aug 16 2022
SELL
Open market or private sale
$32,068 $4.55 p/Share
7,048 Reduced 1.75%
396,532 Common Stock
May 17 2022
SELL
Open market or private sale
$23,233 $3.81 p/Share
6,098 Reduced 1.49%
403,580 Common Stock
Apr 09 2022
BUY
Grant, award, or other acquisition
-
168,511 Added 29.14%
409,678 Common Stock
Mar 14 2022
SELL
Open market or private sale
$131,044 $6.69 p/Share
19,588 Reduced 7.51%
241,167 Common Stock
Mar 12 2022
BUY
Grant, award, or other acquisition
-
14,705 Added 5.34%
260,755 Common Stock
Nov 11 2021
SELL
Open market or private sale
$649,586 $21.89 p/Share
29,675 Reduced 10.76%
246,050 Common Stock
Nov 11 2021
BUY
Exercise of conversion of derivative security
$298,827 $10.07 p/Share
29,675 Added 9.72%
275,725 Common Stock
Aug 16 2021
SELL
Open market or private sale
$539,692 $25.42 p/Share
21,231 Reduced 7.94%
246,050 Common Stock
Jun 14 2021
SELL
Open market or private sale
$313,453 $31.63 p/Share
9,910 Reduced 3.58%
266,879 Common Stock
Apr 30 2021
BUY
Grant, award, or other acquisition
-
44,700 Added 13.9%
276,789 Common Stock
Mar 12 2021
SELL
Open market or private sale
$779,021 $42.9 p/Share
18,159 Reduced 7.26%
232,089 Common Stock
Mar 12 2021
BUY
Grant, award, or other acquisition
-
24,936 Added 9.06%
250,248 Common Stock
Jan 06 2021
BUY
Exercise of conversion of derivative security
$100,000 $9.9 p/Share
10,101 Added 4.29%
225,312 Common Stock
Oct 09 2020
BUY
Exercise of conversion of derivative security
$64,845 $9.9 p/Share
6,550 Added 2.95%
215,211 Common Stock
Jan 03 2017
BUY
Exercise of conversion of derivative security
$2,099 $1.26 p/Share
1,666 Added 50.0%
1,666 Common Stock
RLN

Robert L Nussbaum

Chief Medical Officer
San Francisco, CA

Track Institutional and Insider Activities on NVTA

Follow Invitae Corp and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells NVTA shares.

Notify only if

Insider Trading

Get notified when an Invitae Corp insider buys or sells NVTA shares.

Notify only if

News

Receive news related to Invitae Corp

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on NVTA